Janus Henderson Group PLC Has $9.55 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Janus Henderson Group PLC lowered its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 26.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 104,991 shares of the company's stock after selling 37,455 shares during the quarter. Janus Henderson Group PLC's holdings in Colgate-Palmolive were worth $9,547,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Kohmann Bosshard Financial Services LLC acquired a new stake in Colgate-Palmolive during the 4th quarter worth about $26,000. Centricity Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $27,000. Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $32,000. Briaud Financial Planning Inc acquired a new position in Colgate-Palmolive in the 4th quarter valued at approximately $32,000. Finally, Wintrust Investments LLC purchased a new stake in Colgate-Palmolive in the 4th quarter worth approximately $33,000. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

Shares of CL traded up $0.49 during trading hours on Monday, reaching $91.72. 3,769,888 shares of the company traded hands, compared to its average volume of 4,654,734. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock's fifty day moving average is $91.67 and its 200 day moving average is $91.26. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The stock has a market cap of $74.33 billion, a P/E ratio of 26.06, a price-to-earnings-growth ratio of 4.20 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The company's quarterly revenue was down 3.0% on a year-over-year basis. During the same quarter last year, the company earned $0.86 EPS. Equities research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were given a dividend of $0.52 per share. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a dividend yield of 2.27%. The ex-dividend date was Thursday, April 17th. Colgate-Palmolive's payout ratio is 58.76%.

Colgate-Palmolive declared that its board has approved a stock buyback program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the company to reacquire up to 6.8% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's board of directors believes its shares are undervalued.

Analyst Ratings Changes

A number of brokerages have commented on CL. Citigroup boosted their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. StockNews.com lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Royal Bank of Canada reissued a "sector perform" rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Stifel Nicolaus cut their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a report on Monday, February 3rd. Finally, Raymond James reiterated an "outperform" rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have given a buy rating to the company's stock. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of "Hold" and an average target price of $102.12.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.